| 000 | 01716 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517214933.0 | ||
| 264 | 0 | _c20191203 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1552-4604 | ||
| 024 | 7 |
_a10.1002/jcph.1253 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMehta, Rashmi | |
| 245 | 0 | 0 |
_aPopulation Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _c11 2018 |
||
| 300 |
_a1461-1467 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAndrostadienes _xpharmacokinetics |
| 650 | 0 | 4 |
_aBenzyl Alcohols _xpharmacokinetics |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aChlorobenzenes _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMonte Carlo Method |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aQuinuclidines _xpharmacokinetics |
| 650 | 0 | 4 | _aRandom Allocation |
| 700 | 1 | _aPefani, Eleni | |
| 700 | 1 | _aBeerahee, Misba | |
| 700 | 1 | _aBrealey, Noushin | |
| 700 | 1 | _aBarnacle, Helen | |
| 700 | 1 | _aBirk, Ruby | |
| 700 | 1 | _aZhu, Chang-Qing | |
| 700 | 1 | _aLipson, David A | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 58 _gno. 11 _gp. 1461-1467 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcph.1253 _zAvailable from publisher's website |
| 999 |
_c28392923 _d28392923 |
||